131 related articles for article (PubMed ID: 29020462)
1. Syk inhibitor R406 downregulates inflammation in an in vitro model of Pseudomonas aeruginosa infection.
Alhazmi A; Choi J; Ulanova M
Can J Physiol Pharmacol; 2018 Feb; 96(2):182-190. PubMed ID: 29020462
[TBL] [Abstract][Full Text] [Related]
2. Piceatannol modulates lung epithelial cellular responses to Pseudomonas aeruginosa.
Aval PS; Werner J; Cerqueira A; Balfour-Boehm J; Ulanova M
Inflamm Allergy Drug Targets; 2013 Oct; 12(5):297-307. PubMed ID: 23713607
[TBL] [Abstract][Full Text] [Related]
3. Spleen tyrosine kinase inhibitor R406 has both antiviral and anti-inflammatory effects on severe influenza A infection.
Luo J; Gao Y; Guo W; Zhao S; Li L; Zhang Z; Gao R
J Med Virol; 2024 May; 96(5):e29678. PubMed ID: 38751128
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of spleen tyrosine kinase signaling protects against acute lung injury through blockade of NADPH oxidase and IL-17A in neutrophils and γδ T cells respectively in mice.
Nadeem A; Ahmad SF; Al-Harbi NO; Al-Harbi MM; Ibrahim KE; Kundu S; Attia SM; Alanazi WA; AlSharari SD
Int Immunopharmacol; 2019 Mar; 68():39-47. PubMed ID: 30611000
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic inhibition of spleen tyrosine kinase in inflammatory macrophages using PLGA nanoparticles for the treatment of non-alcoholic steatohepatitis.
Kurniawan DW; Jajoriya AK; Dhawan G; Mishra D; Argemi J; Bataller R; Storm G; Mishra DP; Prakash J; Bansal R
J Control Release; 2018 Oct; 288():227-238. PubMed ID: 30219279
[TBL] [Abstract][Full Text] [Related]
6. Carbon monoxide releasing molecule-2 attenuates Pseudomonas aeruginosa-induced ROS-dependent ICAM-1 expression in human pulmonary alveolar epithelial cells.
Lee CW; Wu CH; Chiang YC; Chen YL; Chang KT; Chuang CC; Lee IT
Redox Biol; 2018 Sep; 18():93-103. PubMed ID: 30007888
[TBL] [Abstract][Full Text] [Related]
7. A novel spleen tyrosine kinase inhibitor blocks c-Jun N-terminal kinase-mediated gene expression in synoviocytes.
Cha HS; Boyle DL; Inoue T; Schoot R; Tak PP; Pine P; Firestein GS
J Pharmacol Exp Ther; 2006 May; 317(2):571-8. PubMed ID: 16452391
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Benefits of Spleen Tyrosine Kinase Inhibitor Administration on Binge Drinking-Induced Alcoholic Liver Injury, Steatosis, and Inflammation in Mice.
Bukong TN; Iracheta-Vellve A; Gyongyosi B; Ambade A; Catalano D; Kodys K; Szabo G
Alcohol Clin Exp Res; 2016 Jul; 40(7):1524-30. PubMed ID: 27177528
[TBL] [Abstract][Full Text] [Related]
9. R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation.
Braselmann S; Taylor V; Zhao H; Wang S; Sylvain C; Baluom M; Qu K; Herlaar E; Lau A; Young C; Wong BR; Lovell S; Sun T; Park G; Argade A; Jurcevic S; Pine P; Singh R; Grossbard EB; Payan DG; Masuda ES
J Pharmacol Exp Ther; 2006 Dec; 319(3):998-1008. PubMed ID: 16946104
[TBL] [Abstract][Full Text] [Related]
10. Aerosolized bovine lactoferrin reduces neutrophils and pro-inflammatory cytokines in mouse models of Pseudomonas aeruginosa lung infections.
Valenti P; Frioni A; Rossi A; Ranucci S; De Fino I; Cutone A; Rosa L; Bragonzi A; Berlutti F
Biochem Cell Biol; 2017 Feb; 95(1):41-47. PubMed ID: 28129511
[TBL] [Abstract][Full Text] [Related]
11. The Syk inhibitor R406 is a modulator of P-glycoprotein (ABCB1)-mediated multidrug resistance.
Duran GE; Sikic BI
PLoS One; 2019; 14(1):e0210879. PubMed ID: 30668583
[TBL] [Abstract][Full Text] [Related]
12. Spleen Tyrosine Kinase as a Target Therapy for Pseudomonas aeruginosa Infection.
Alhazmi A
J Innate Immun; 2018; 10(4):255-263. PubMed ID: 29925062
[TBL] [Abstract][Full Text] [Related]
13. The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC-2 signaling in platelets.
Spalton JC; Mori J; Pollitt AY; Hughes CE; Eble JA; Watson SP
J Thromb Haemost; 2009 Jul; 7(7):1192-9. PubMed ID: 19422460
[TBL] [Abstract][Full Text] [Related]
14. Blocking TNF-α enhances Pseudomonas aeruginosa-induced mortality in burn mice through induction of IL-1β.
Tsay TB; Yang MC; Chen PH; Lai KH; Huang HT; Hsu CM; Chen LW
Cytokine; 2013 Jul; 63(1):58-66. PubMed ID: 23623770
[TBL] [Abstract][Full Text] [Related]
15. The Syk-kinase inhibitor R406 impairs platelet activation and monocyte tissue factor expression triggered by heparin-PF4 complex directed antibodies.
Lhermusier T; van Rottem J; Garcia C; Xuereb JM; Ragab A; Martin V; Gratacap MP; Sié P; Payrastre B
J Thromb Haemost; 2011 Oct; 9(10):2067-76. PubMed ID: 21848694
[TBL] [Abstract][Full Text] [Related]
16. The antioxidant resveratrol down-regulates inflammation in an in-vitro model of Pseudomonas aeruginosa infection of lung epithelial cells.
Cerqueira AM; Khaper N; Lees SJ; Ulanova M
Can J Physiol Pharmacol; 2013 Mar; 91(3):248-55. PubMed ID: 23537439
[TBL] [Abstract][Full Text] [Related]
17. Pseudomonas aeruginosa induces p38MAP kinase-dependent IL-6 and CXCL8 release from bronchial epithelial cells via a Syk kinase pathway.
Coates MS; Alton EWFW; Rapeport GW; Davies JC; Ito K
PLoS One; 2021; 16(2):e0246050. PubMed ID: 33524056
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Spleen Tyrosine Kinase Restores Glucocorticoid Sensitivity to Improve Steroid-Resistant Asthma.
Liu Q; Hua L; Bao C; Kong L; Hu J; Liu C; Li Z; Xu S; Liu X
Front Pharmacol; 2022; 13():885053. PubMed ID: 35600871
[TBL] [Abstract][Full Text] [Related]
19. Royal Jelly Inhibits
Susilowati H; Murakami K; Yumoto H; Amoh T; Hirao K; Hirota K; Matsuo T; Miyake Y
Biomed Res Int; 2017; 2017():3191752. PubMed ID: 29075644
[No Abstract] [Full Text] [Related]
20. Blockade of Syk ameliorates the development of murine sclerodermatous chronic graft-versus-host disease.
Le Huu D; Kimura H; Date M; Hamaguchi Y; Hasegawa M; Hau KT; Fujimoto M; Takehara K; Matsushita T
J Dermatol Sci; 2014 Jun; 74(3):214-21. PubMed ID: 24679982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
